His primary areas of investigation include Immunology, Multiple sclerosis, Myelin oligodendrocyte glycoprotein, Antibody and Pathology. Thomas Berger studied Multiple sclerosis and Autoantibody that intersect with Aquaporin 4. Thomas Berger combines subjects such as Epitope, Encephalomyelitis, Myelin basic protein and Acute disseminated encephalomyelitis with his study of Myelin oligodendrocyte glycoprotein.
His work deals with themes such as Cellular differentiation, Central nervous system and Bioavailability, which intersect with Antibody. His study in Pathology is interdisciplinary in nature, drawing from both Magnetic resonance imaging and Microglia. His Clinically isolated syndrome study combines topics in areas such as Gastroenterology and Internal medicine, Central nervous system disease.
Multiple sclerosis, Randomized controlled trial, Clinical psychology, Immunology and Psychological intervention are his primary areas of study. His Multiple sclerosis research is multidisciplinary, incorporating elements of Myelin and Internal medicine, Disease, Pathology. Thomas Berger works mostly in the field of Randomized controlled trial, limiting it down to topics relating to Physical therapy and, in certain cases, Quality of life, as a part of the same area of interest.
Thomas Berger interconnects Psychotherapist, Social anxiety, Psychiatry and Internet based in the investigation of issues within Clinical psychology. His Immunology study is mostly concerned with Antibody, Myelin oligodendrocyte glycoprotein, Autoantibody, Neuromyelitis optica and Antigen. The Psychological intervention study combines topics in areas such as Mental health and Cognitive behavioral therapy.
Thomas Berger spends much of his time researching Randomized controlled trial, Psychological intervention, Intervention, Clinical psychology and Depression. His study in Randomized controlled trial focuses on Cognitive behavioral therapy in particular. His study explores the link between Psychological intervention and topics such as Psychosis that cross with problems in Schizophrenia.
His research in Intervention focuses on subjects like Clinical trial, which are connected to Affect and Sample. In the field of Clinical psychology, his study on Distress overlaps with subjects such as Alliance. His Depression research is multidisciplinary, incorporating elements of Psychotherapist, Blended treatment, Meta-analysis and MEDLINE.
His primary scientific interests are in Randomized controlled trial, Psychological intervention, Intervention, Multiple sclerosis and Clinical psychology. His Randomized controlled trial research is multidisciplinary, relying on both Physical therapy, Psychopathology, Depression and Anxiety. In Psychological intervention, Thomas Berger works on issues like Meta-analysis, which are connected to Outcome and Internet based interventions.
The concepts of his Intervention study are interwoven with issues in Medical emergency, Position paper, Disease and Quality of life. His Multiple sclerosis research integrates issues from Disability progression, Retinal and Neuroscience, Olfactory system. His research in Clinical psychology intersects with topics in Patient satisfaction and Mental health.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event
Thomas Berger;Paul Rubner;Franz Schautzer;Robert Egg.
The New England Journal of Medicine (2003)
A synaptic organizing principle for cortical neuronal groups
Rodrigo Perin;Thomas K. Berger;Henry Markram.
Proceedings of the National Academy of Sciences of the United States of America (2011)
Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
Monika Bradl;Tatsuro Misu;Toshiyuki Takahashi;Mitsutoshi Watanabe.
Annals of Neurology (2009)
Heterogeneity in the pyramidal network of the medial prefrontal cortex
Yun Wang;Henry Markram;Philip H Goodman;Thomas K Berger.
Nature Neuroscience (2006)
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
Simone Mader;Viktoria Gredler;Kathrin Schanda;Kevin Rostasy.
Journal of Neuroinflammation (2011)
Antibody to aquaporin-4 in the Long-Term Course of Neuromyelitis Optica
S Jarius;F Aboul-Enein;P Waters;B Kuenz.
Brain (2008)
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Markus Reindl;Chris Linington;Uschi Brehm;Robert Egg.
Brain (1999)
Effectiveness of a Novel Integrative Online Treatment for Depression (Deprexis): Randomized Controlled Trial
Björn Meyer;Thomas Berger;Franz Caspar;Christopher G Beevers.
Journal of Medical Internet Research (2009)
The spectrum of MOG autoantibody-associated demyelinating diseases
Markus Reindl;Franziska Di Pauli;Kevin Rostásy;Thomas Berger.
Nature Reviews Neurology (2013)
Internet-Based Treatment of Depression: A Randomized Controlled Trial Comparing Guided with Unguided Self-Help
Thomas Berger;Katja Hämmerli;Nina Gubser;Gerhard Andersson.
Cognitive Behaviour Therapy (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Innsbruck Medical University
Universität Hamburg
Linköping University
City, University of London
University of Lübeck
Vrije Universiteit Amsterdam
University of Trier
Vrije Universiteit Amsterdam
Stockholm University
Technical University of Munich
Google (United States)
University of Groningen
Jilin University
West Virginia University
Imperial College London
New Jersey Institute of Technology
University of Melbourne
The University of Texas at Austin
Kyushu University
Broad Institute
Case Western Reserve University
University of Pennsylvania
Tokyo Medical University
University of Duisburg-Essen
University of Ljubljana
Stanford University